U.S. Corporate Ventures Group, Inc.
   Our Services
Divestiture of Non-Strategic and Partially Impaired Investments

U.S. Corporate Ventures Group advises corporate clients seeking to discretely liquidate non-strategic and impaired direct investments. We thoughtfully determine how to return maximum value to our clients in consideration of the following:
  • which investments to sell individually and which to bundle in a portfolio
  • what buyers to approach as likely to appreciate the investment value
  • structuring a competitive bidding process
  • negotiating effectively to provide maximum returns

Value Added Benefits:

  • Realize immediate proceeds from illiquid private and public investments. Funds may be redirected for strategic purposes.
  • Recover approximately 40% of investment losses in the form of tax benefits
  • Realize accounting gains at the time of sale
  • Clean the balance sheet of previous investment assets held below original cost basis
  • Clear the administrative burden, cost and risk of maintaining investments
  • Improve the risk profile of the overall portfolio
  • Free the investment team to focus on the core investment strategy

U.S. CVG Case Study - Divestitures for a Corporate Strategic Venture Group:

  • Managed the divestitures of 15 direct investments with an aggregate original cost basis of $125 million.
  • Investments were sold individually to investors with an appreciation for the value returning greater than projected proceeds
  • Realized over $40 million of tax benefits, $35 million which would have otherwise expired
  • Identified investors to acquire 40% interest in a public entity triggering a public market sale of over $50 million
Please reach Michael Seidler or Philip Limeri to discuss how we may help you achieve your objectives.

Copyright © 2005, U.S. Corporate Ventures Group, Inc. All rights reserved.